Related Experiment Videos

Transcranial magnetic stimulation as a biomarker for epilepsy

Prisca R Bauer^1,2, Annika A de Goede³, Esther M Ter Braack³

¹NIHR University College London Hospitals Biomedical Research Centre, UCL Institute of Neurology, Department of Clinical and Experimental Epilepsy, London WC1N 3BG, UK.

Brain : a Journal of Neurology

|April 2, 2017

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Sustained pharmacodynamic effects of S-ketamine on cortical excitability and resting-state brain activity: A randomized, placebo-controlled trial.

British journal of clinical pharmacology·2026

Transcranial Magnetic Stimulation as a Translational Biomarker in Early-Phase Anti-Seizure Medication Development: A Randomized, Double-Blind, Placebo-Controlled Study in Generalized Epilepsy.

Clinical pharmacology and therapeutics·2026

Saint Valentine and Epilepsy: from Medieval Devotion to Modern Global Advocacy.

Arquivos de neuro-psiquiatria·2026

Genetic risk, antiseizure medications, and lifestyle factors in epilepsy-associated obesity and overweight.

International journal of obesity (2005)·2026

EEG features in late-onset epilepsy: possible correlation with cognitive impairment.

Brain communications·2026

One year of seizure freedom reduces premature death in people with epilepsy in rural China: A 10-year cohort study.

Epilepsia·2026

See all related articles